In the near future, I will be introducing legislation to create the Pennsylvania Cannabis Control Board (CCB), which will assume oversight of both the state’s Medical Marijuana Program and the currently unregulated products proliferating throughout the Commonwealth.

Since the enactment of Act 16 of 2016, the Pennsylvania Department of Health’s oversight of the Medical Marijuana Program has been plagued by regulatory inconsistencies, lack of transparency, and inefficiencies that have frustrated patients and businesses alike. This failure has underscored the need for a dedicated regulatory body with the expertise and resources necessary to effectively manage and oversee the industry.

This legislation will transfer regulatory control of the Medical Marijuana Program to the CCB, ensuring continuity, efficiency, and improved oversight of medical cannabis businesses and patient access. Additionally, it will establish uniform safety standards to protect consumers from untested and potentially harmful products.

Please join me in co-sponsoring this important piece of legislation. By consolidating oversight under a single regulatory board, we can eliminate inconsistencies, enhance transparency, and provide the structure needed to responsibly manage this industry.